Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, et al. Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. Am J Hematol 2022 Aug 12. doi: 10.1002/ajh.26686.
PMID: 36054756